Home > Compound List > Product Information
Toceranib-d8_Molecular_structure_CAS_)
Click picture or here to close

Toceranib-d8

Catalog No. T525502 Name Toronto Research Chemicals
CAS Number Website http://www.trc-canada.com
M. F. C22H25FN4O2 Telephone +1 (416) 665-9696
M. W. 396.4579032 Fax +1 (416) 665-4439
Purity Email info@trc-canada.com
Storage Chembase ID: 178687

SYNONYMS

IUPAC name
5-{[(3Z)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-2,4-dimethyl-N-{2-[(2H8)pyrrolidin-1-yl]ethyl}-1H-pyrrole-3-carboxamide
IUPAC Traditional name
5-{[(3Z)-5-fluoro-2-oxo-1H-indol-3-ylidene]methyl}-2,4-dimethyl-N-{2-[(2H8)pyrrolidin-1-yl]ethyl}-1H-pyrrole-3-carboxamide
Synonyms
5-[(Z)-(5-Fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-[2-(1-pyrrolidinyl-d8)ethyl]-1H-pyrrole-3-carboxamide
PHA 291639
5-(5-Fluoro-2-oxo-1,2-dihydroindol-(3Z)-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic Acid (2-(Pyrrolidin-1-yl-d8)ethyl)amide
SU 11654

DATABASE IDS

PROPERTIES

Certificate of Analysis Download
MSDS Link Download

DETAILS

Description (English)
Labelled Toceranib, a multitargeted indolinone receptor tyrosine kinase (RTK) inhibitor. Toceranib exhibited activity against a variety of spontaneous malignancies in canine such as mast cell tumors, mixed mammary carcinomas, soft tissue sarcomas, and mul

REFERENCES

  • London, C.A. et al.: Clin. Cancer Res., 9, 2755 (2003)
  • Zavodovskaya, R. et al.: Am. J. Vet. Res., 67, 633 (2003)
  • Malone, E.K. et al.: Vet. Comp. Oncol., 8, 209 (2003)